){kind=logo}
Case Study // Innovating Animal Health: The Future of Vaccine R&D
- How can we accelerate vaccine innovation to respond rapidly to emerging animal diseases?
- In what ways can vaccine R&D keep pace with diseases like Epizootic haemorrhagic disease (EHD) that spread quickly through vectors like mosquitos and change epidemiologically by season and region?
- What are the main regulatory, logistical, and strategic challenges in moving animal vaccines from emergency use to full marketing authorization across multiple regions - and how can cross-border alignment be improved to ensure faster and more consistent vaccine access?
- Could a next-generation vaccine against African Swine Fever (ASF) virus pave the way for global eradication of the disease?
- Could 'plug and play' veterinary vaccine platforms, built on advanced technologies and a One Health approach, deliver safe, scalable, and cost-effective vaccines for animals and humans?
){kind=logo}
){kind=logo}
)
)
){kind=logo}